Viewing Study NCT04009967


Ignite Creation Date: 2025-12-25 @ 12:27 AM
Ignite Modification Date: 2026-01-02 @ 2:36 AM
Study NCT ID: NCT04009967
Status: ACTIVE_NOT_RECRUITING
Last Update Posted: 2025-01-13
First Post: 2019-06-17
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Biomarkers for Neoadjuvant Pembrolizumab in Non-Metastatic Prostate Cancer Positive by 18FDG-PET Scanning
Sponsor: CHU de Quebec-Universite Laval
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module